All Type of News
Price of Fuzeon to be determined
Pharmaceutical sources say that the Ministry for Health, Welfare and Family Affair committee will determine the price of Fuzeon, a new drug for AIDS.
The Health Insurance Review Agency says Fuzeon is an essential d...
Makers of ginkgo biloba preparations to face sizable sales loss
SK Chemicals and Yuyu Pharm, the nation’s leading manufacturers for ginkgo biloba preparations, will likely see their sales plunge as these medicines can be reimbursed only for enhancement of cognitive function.
So...
Daewoong to step up OTC business
As pharmaceutical companies are competing to take a bigger stake in the domestic OTC market, Daewoong Pharm is activating its OTC business unit by separating it from ethical business unit.
“We are separating the tw...
Tanamin surpasses 120 million tablets in prescription
Yuyu Pharm says its blood circulation enhancer Tanamin (EGb 761) is emerging as one of the Korean’s popular prescription drugs.
Tanamin exceeded 120 million tablets in the quantity of prescription last year based o...
Novotech launches Korean unit
Novotech Inc says it established Novotech Asia Korea, its Korean unit, to offer clinical research services in Asia.
Novotech is the largest independent CRO in Australia. With operations in the US, Novotech is idea...
Price of new AIDS medication angers patients
Can AIDS patients be able to get cheaper and better drugs this year?
Now all eyes are on the Ministry for Health, Welfare and Family Affair committee's decision on the price of Fuzeon, a new drug for the disease.
...
Health insurance reimbursement for hyperlipidemic treatment should be modified
The pharmacoeconomic issues of individual antihyperlipidemic agents should be evaluated in terms of various factors, according to the Korean Society of Cardiology and the Korean Society of Lipidology and Atheroscleros...
70% of pharmaceutical firms conducting validation for ethicals
The national health watchdog's recent survey of 190 pharmaceutical firms showed that over 70 percent of those surveyed are conducting their validation on 800 prescription drugs.
The survey also revealed that each p...
SK teams up with MSD Korea over losartan
SK Chemicals and MSD Korea entered into an agreement to conduct the joint marketing of COSKAR PLUS and COSKAR PLUS F on April 24.
COSKAR PLUS and COSKAR PLUS F contain losartan, which has been marketed by the trade...
Doctors seeking to implement two-dimensional barcode project
The Korean Medical Association plans to set up a new committee aiming to independently implement the standardized drug bar-code (KD code) for prescription.
The KMP said in a statement that the new barcode project s...
